Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated Disorder
Study Details
Study Description
Brief Summary
To determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Detailed Description
This is a double-blind, randomized controlled trial to determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury. Outcomes include pain, objective assessment, self-report function recovery, impact on work performance and globe perceived effects which will be assessed 5 minutes, 2 and 6 weeks following injection.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: lidocaine The treatment group will receive a 25 gauge, 40mm long needle, pre-filled with 1% lidocaine inserting into the site of the trigger point. Three to five points injection. |
Procedure: Lidocaine
Lidocaine injection 3-5 points in experimental group( using 25 gauge, 40mm long needle, pre-filled with 1% lidocaine inserting into the site of the trigger point).
|
Active Comparator: Saline The control group will receive a 25 gauge, 40mm long needle, pre-filled with saline inserting to subcutis. |
Other: Saline
The control group will receive a 25 gauge, 40mm long needle, pre-filled with saline inserting to subcutis.
|
Outcome Measures
Primary Outcome Measures
- pain [2 weeks following injection]
10 cm Visual Analog Scale
Secondary Outcome Measures
- cervical range of motion [Immediately, 2 and 6 weeks after injection]
- self-report neck disability [Immediately, 2 and 6 weeks after injection]
- globe perceived effects [Immediately, 2 and 6 weeks after injection]
The Short Form-12
- work performance [Immediately, 2 and 6 weeks after injection]
questionnaire
- pain [5 minutes following injection]
10 cm Visual Analog Scale
- pain [6 weeks following injection]
10 cm Visual Analog Scale
Eligibility Criteria
Criteria
Inclusion Criteria:
-
fulfill the Grade II Quebec Task Force classification of WAD,
-
with identifiable myofascial trigger points ( which occur with or without a taut band),
-
reproduction of recognizable pain with sustained pressure ( up to 10 seconds) on trigger points
-
aged 18 to 70
-
a good understanding of informed consent and willing to attend this trial.
Exclusion Criteria:
-
have serious injury such as fracture and internal bleeding
-
suspicion of upper cervical instability or neurological deficits
-
clinical evidence of radiculopathy
-
a history of active cancer, central nerve disorder, blood clotting disorders, needle phobia
-
anticoagulant medication user
-
previous experience with any type of needling for myofascial pain
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of physical medicine and rehabilitation, McMaster University | Hamilton | Ontario | Canada | L8V 1C3 |
2 | HHS (Juravinski Hospital Site) | Hamilton | Ontario | Canada | L8V 1C3 |
Sponsors and Collaborators
- Hamilton Health Sciences Corporation
Investigators
- Study Director: Joy MacDermid, Ph.D., McMaster University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HHSCTRIGGERINJ1402